title: Developing evidence-based immunization recommendations and GRADE.
abstract: The Strategic Group of Advisory Experts (SAGE) on immunization is an independent advisory committee with a mandate to advise the World Health Organization (WHO) on the development of vaccine and immunization related policies. SAGE working groups are established on a time-limited basis to review and provide evidence-based recommendations, together with their implications, for open deliberation and decision-making by SAGE. In making its recommendations, SAGE takes into consideration: the epidemiologic and clinical characteristics of the disease; vaccine and immunization characteristics; economic analysis; health system considerations; the existence of and interaction with other intervention and control strategies; costing and social impacts; and legal and ethical concerns. Since 1998, WHO has produced evidence-based vaccine position papers for use primarily by national public health officials and immunization programme managers. Since April 2006 all new or updated position papers have been based on SAGE recommendations. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach has been adopted by WHO and, since 2008, GRADE tables that rate the quality of evidence have been produced in support of key recommendations. SAGE previously expressed concern that GRADE was not ideally suited to many immunization-specific issues such as the vaccine population level effect and the inclusion of surveillance system data, particularly for vaccine safety. Extensive productive interactions with various advisory groups including the US Advisory Committee on Immunization Practices, the European Centres for Disease Control, the German Standing Committee on Vaccination (STIKO), WHO's Global Advisory Committee on Vaccine Safety and the GRADE working group resulted in key enhancements to accommodate vaccine-relevant evidence. This facilitated integration and acceptability of the GRADE approach in the development of immunization related SAGE and WHO recommendations. Ongoing utilisation should result in further fine-tuning of the approach to ensure that recommendations are based on the full range of appropriate evidence.
authors.affiliation: Immunization, Vaccines and Biologicals, World Health Organization, 20 Ave Appia, CH-1211 Geneva 27, Switzerland. duclosp@who.int
authors.forename: P
authors.initials: P
authors.lastname: Duclos
authors.forename: D N
authors.initials: DN
authors.lastname: Durrheim
authors.forename: A L
authors.initials: AL
authors.lastname: Reingold
authors.forename: Z A
authors.initials: ZA
authors.lastname: Bhutta
authors.forename: K
authors.initials: K
authors.lastname: Vannice
authors.forename: H
authors.initials: H
authors.lastname: Rees
mesh_terms: D006801:Humans; D007114:Immunization / Q000379:methods*; D017589:Immunization Programs; D014944:World Health Organization